Curable Trans-1,2-cyclohexane bis(urea-urethane) compounds

ABSTRACT

Curable trans-1,2-cyclohexane bis(urea-urethane) compounds of the formulae  
                 
 
wherein R 1  and R′ 1  each, independently of the other, are alkylene, arylene, arylalkylene, or alkylarylene groups, R 2  and R′ 2  each, independently of the other, are alkyl, aryl, arylalkyl, or alkylaryl groups, R 3  and R′ 3  each, independently of the other, are hydrogen atoms or alkyl groups, R 4  and R′ 4  each, independently of the other, are hydrogen atoms, fluorine atoms, alkyl groups, or phenyl groups, n is an integer of 0, 1, 2, 3, or 4, and R 5  is an alkyl, aryl, arylalkyl, or alkylaryl group, or a substituent other than an alkyl, aryl, arylalkyl, or alkylaryl group, provided that at least one of R 1 , R′ 1 , R 2 , R′ 2 , R 3 , R′ 3 , R 4 , R′ 4 , or one or more of R 5  is an alkyl, alkylene, arylalkyl, arylalkylene, alkylaryl, or alkylarylene group containing an ethylenic unsaturation rendering the compound curable upon exposure to heat and/or actinic radiation.

CROSS-REFERENCE TO RELATED APPLICATIONS

Copending application U.S. Ser. No. (not yet assigned; Attorney Docket No. A3592-US-NP), filed concurrently herewith, entitled “Trans-1,2-cyclohexane bis(urea-urethane) Compounds,” with the named inventors Adela Goredema, Rina Carlini, Marcel P. Breton, Jeffery H. Banning, and Eniko Toma, the disclosure of which is totally incorporated herein by reference, discloses trans-1,2-cyclohexane bis(urea-urethane) compounds of the formulae

wherein R₁ and R′₁ each, independently of the other, is an alkylene group, an arylene group, an arylalkylene group, or an alkylarylene group, R₂ and R′₂ each, independently of the other, is an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, R₃ and R′₃ each, independently of the other, is a hydrogen atom or an alkyl group, R₄ and R′₄ each, independently of the other, is a hydrogen atom, a fluorine atom, an alkyl group, or a phenyl group, n is an integer of 0, 1, 2, 3, or 4, and R₅ is an alkyl group, an aryl group, an arylalkyl group, an alkylaryl group, or a substituent other than an alkyl, aryl, arylalkyl, or alkylaryl group.

Copending application U.S. Ser. No. (not yet assigned; Attorney Docket No. A3592Q-US-NP), filed concurrently herewith, entitled “Phase Change Inks Containing Trans-1,2-cyclohexane bis(urea-urethane) Compounds,” with the named inventors Adela Goredema, Rina Carlini, Marcel P. Breton, and Jeffery H. Banning, the disclosure of which is totally incorporated herein by reference, discloses phase change inks comprising a phase change ink carrier and a trans-1,2-cyclohexane bis(urea-urethane) compound of the formula

or mixtures thereof, wherein R₁ and R′₁ each, independently of the other, is an alkylene group, an arylene group, an arylalkylene group, or an alkylarylene group, R₂ and R′₂ each, independently of the other, is an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, R₃ and R′₃ each, independently of the other, is a hydrogen atom or an alkyl group, R₄ and R′₄ each, independently of the other, is a hydrogen atom, a fluorine atom, an alkyl group, or a phenyl group, n is an integer of 0, 1, 2, 3, or 4, and R₅ is an alkyl group, an aryl group, an arylalkyl group, an alkylaryl group, or a substituent other than an alkyl, aryl, arylalkyl, or alkylaryl group.

Copending application U.S. Ser. No. (not yet assigned; Attorney Docket No. A3593-US-NP), filed concurrently herewith, entitled “Bis(urea-urethane) Compounds and Phase Change Inks Containing Same,” with the named inventors Adela Goredema, Rina Carlini, Christine E. Bedford, Marcel P. Breton, and Eniko Toma, the disclosure of which is totally incorporated herein by reference, discloses a bis(urea-urethane) compound of the formula

wherein R₁ and R₁′ each, independently of the other, is an alkyl group, wherein at least one of R₁ and R₁′ has at least about 6 carbon atoms, R₂ and R₂′ each, independently of the other, is an alkylene group, wherein at least one of R₂ and R₂′ has at least about 3 carbon atoms, R₃ is an alkylene group having at least about 2 carbon atoms, and R₄ and R₅ each, independently of the other, is a hydrogen atom or an alkyl group, and wherein R₁ and R₁′ each contain no more than 2 fully fluorinated carbon atoms.

Copending application U.S. Ser. No. (not yet assigned; Attorney Docket No. A3593Q-US-NP), filed concurrently herewith, entitled “Phase Change Inks Containing Bis(urea-urethane) Compounds,” with the named inventors Adela Goredema, Rina Carlini, Christine E. Bedford, and Marcel P. Breton, the disclosure of which is totally incorporated herein by reference, discloses a phase change ink composition comprising a phase change ink carrier and a bis(urea-urethane) compound of the formula

wherein R₁ and R₁′ each, independently of the other, is an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, R₂ and R₂′ each, independently of the other, is an alkylene group, an arylene group, an arylalkylene group, or an alkylarylene group, R₃ is an alkylene group, an arylene group, an arylalkylene group, or an alkylarylene group, and R₄ and R₅ each, independently of the other, is a hydrogen atom or an alkyl group.

Copending application U.S. Ser. No. (not yet assigned; Attorney Docket No. A3593Q1-US-PSP), filed concurrently herewith, entitled “Processes for Preparing Bis(urea-urethane) Compounds,” with the named inventor Adela Goredema, the disclosure of which is totally incorporated herein by reference, discloses a process for preparing bis(urea-urethane) compounds of the formula

wherein R₁ is an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, R₂ is an alkylene group, an arylene group, an arylalkylene group, or an alkylarylene group, R₃ is an alkylene group, an arylene group, an arylalkylene group, or an alkylarylene group, and R₄ is a hydrogen atom or an alkyl group, said process comprising: (1) first adding a monoalcohol reactant of the formula R₁—OH to a diisocyanate reactant of the formula OCN—R₂—NCO, said monoalcohol being added in an amount of from about 0.8 mole of monoalcohol per every one mole of diisocyanate to about 1.2 moles of monoalcohol per every one mole of diisocyanate, said monoalcohol and said diisocyanate reactants being admixed in a solvent, said reactants and said solvent being present in a relative amount of at least about 10 milliliters of solvent per every 1 millimole of diisocyanate, said addition of monoalcohol occuring while heating the diisocyanate and the solvent to a temperature of from about 25° C. to about 125° C.; (2) subsequent to addition of the monoalcohol, maintaining the temperature of the reaction mixture thus formed at a temperature of from about 25° C. to about 125° C. until the reaction between the monoalcohol and the diisocyanate is complete; and (3) subsequent to step (2), adding to the reaction mixture a diamine of the formula

without isolating the reaction product of step (2), thereby forming a compound of the formula

in desirably high yield.

Copending application U.S. Ser. No. (not yet assigned; Attorney Docket No. 20030935Q-US-NP), filed concurrently herewith, entitled “Phase Change Inks Containing Curable Trans-1,2-cyclohexane bis(urea-urethane) Compounds,” with the named inventors Rina Carlini, Eniko Toma, Peter G. Odell, and Jeffery H. Banning, the disclosure of which is totally incorporated herein by reference, discloses phase change inks comprising a phase change ink carrier and one or more curable trans-1,2-cyclohexane bis(urea-urethane) compounds of the formulae

wherein R₁ and R′₁ are alkylene, arylene, arylalkylene, or alkylarylene groups, R₂ and R′₂ are alkyl, aryl, arylalkyl, or alkylaryl groups, R₃ and R′₃ are hydrogen atoms or alkyl groups, R₄ and R′₄ are hydrogen atoms, fluorine atoms, alkyl groups, or phenyl groups, n is an integer of 0, 1, 2, 3, or 4, and R₅ is an alkyl, aryl, arylalkyl, or alkylaryl group, or a substituent other than an alkyl, aryl, arylalkyl, or alkylaryl group, provided that at least one of R₁, R′₁, R₂, R′₂, R₃, R′₃, R₄, R′₄, or one or more of R₅ is an alkyl, alkylene, arylalkyl, arylalkylene, alkylaryl, or alkylarylene group containing an ethylene unsaturation rendering the compound curable upon exposure to heat and/or actinic radiation.

Copending application U.S. Ser. No. 09/949,315, filed Sep. 7, 2001, U.S. Publication 20030079644, entitled “Aqueous Ink Compositions,” with the named inventors Thomas W. Smith, David J. Luca, and Kathleen M. McGrane, the disclosure of which is totally incorporated herein by reference, discloses an aqueous ink composition comprising an aqueous liquid vehicle, a colorant, and an additive wherein, when the ink has been applied to a recording substrate in an image pattern and a substantial amount of the aqueous liquid vehicle has either evaporated from the ink image, hydrogen bonds of sufficient strength exist between the additive molecules so that the additive forms hydrogen-bonded oligomers or polymers.

Copending application U.S. Ser. No. 09/948,958, filed Sep. 7, 2001, U.S. Publication 20030105185, entitled “Phase Change Ink Compositions,” with the named inventors H. Bruce Goodbrand, Thomas W. Smith, Dina Popovic, Daniel A. Foucher, and Kathleen M. McGrane, the disclosure of which is totally incorporated herein by reference, discloses a phase change ink composition comprising a colorant and an ink vehicle, the ink being a solid at temperatures less than about 50° C. and exhibiting a viscosity of no more than about 20 centipoise at a jetting temperature of no more than about 160° C., wherein at a first temperature hydrogen bonds of sufficient strength exist between the ink vehicle molecules so that the ink vehicle forms hydrogen-bonded dimers, oligomers, or polymers, and wherein at a second temperature which is higher than the first temperature the hydrogen bonds between the ink vehicle molecules are sufficiently broken that fewer hydrogen-bonded dimers, oligomers, or polymers are present in the ink at the second temperature than are present in the ink at the first temperature, so that the viscosity of the ink at the second temperature is lower than the viscosity of the ink at the first temperature.

Copending application U.S. Ser. No. 10/770,305, filed Feb. 2, 2004, U.S. Publication 20040158063, entitled “Alkylated Tetrakis(triaminotriazine) Compounds and Phase Change Inks Containing Same,” with the named inventors Danielle C. Boils Boissier, Marcel P. Breton, Jule W. Thomas, Jr., Donald R. Titterington, Jeffery H. Banning, H. Bruce Goodbrand, James D. Wuest, Marie Eve Perron, Francis Monchamp, and Hugues Duval, the disclosure of which is totally incorporated herein by reference, discloses compounds of the formulae

wherein, provided that at least one of R₁, R₂, R₃, R₄, R₅, and R₆ is a hydrogen atom, and provided that at least one of R₁, R₂, R₃, R₄, R₅, and R₆ is not a hydrogen atom, R₁, R₂, R₃, R₄, R₅, and R₆ each, independently of the others, is (i) a hydrogen atom, (ii) an alkyl group, (iii) an aryl group, (iv) an arylalkyl group, or (v) an alkylaryl group. Also disclosed are phase change ink compositions comprising a colorant and a phase change ink carrier comprising a material of this formula.

Copending application U.S. Ser. No. 10/235,061, filed Sep. 4, 2002, U.S. Publication 20040060474, and Copending application U.S. Ser. No. 10/794,930, filed Mar. 5, 2004, both entitled “Guanidinopyrimidinone Compounds and Phase Change Inks Containing Same,” with the named inventors Danielle C. Boils-Boissier, Marcel P. Breton, Jule W. Thomas, Jr., Donald R. Titterington, Jeffery H. Banning, H. Bruce Goodbrand, James D. Wuest, Marie-Eve Perron, and Hugues Duval, the disclosure of which is totally incorporated herein by reference, discloses compounds of the formulae

wherein, provided that at least one of R₁, R₂, and R₃ is not a hydrogen atom, R₁, R₂, and R₃ each, independently of the other, is (i) a hydrogen atom, (ii) an alkyl group, (iii) an aryl group, (iv) an arylalkyl group, or (v) an alkylaryl group, and wherein R₁ and R₂ can also be (vi) an alkoxy group, (vii) an aryloxy group, (viii) an arylalkyloxy group, (ix) an alkylaryloxy group, (x) a polyalkyleneoxy group, (xi) a polyaryleneoxy group, (xii) a polyarylalkyleneoxy group, (xiii) a polyalkylaryleneoxy group, (xiv) a silyl group, (xv) a siloxane group, (xvi) a polysilylene group, (xvii) a polysiloxane group, or (xviii) a group of the formula

wherein r is an integer representing a number of repeat —CH₂— groups, wherein s is an integer representing a number of repeating —CH₂— groups, and wherein X is (a) a direct bond, (b) an oxygen atom, (c) a sulfur atom, (d) a group of the formula —NR₄₀— wherein R₄₀ is a hydrogen atom, an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, or (e) a group of the formula —CR₅₀R₆₀— wherein R₅₀ and R₆₀ each, independently of the other, is a hydrogen atom, an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, and R₁₀ and R₁₁ each, independently of the other, is (i) an alkylene group, (ii) an arylene group, (iii) an arylalkylene group, or (iv) an alkylarylene group, and wherein R₁₀ can also be (v) a polyalkyleneoxy group, (vi) a polyaryleneoxy group, (vii) a polyarylalkyleneoxy group, (viii) a polyalkylaryleneoxy group, (ix) a silylene group, (x) a siloxane group, (xi) a polysilylene group, or (xii) a polysiloxane group. Also disclosed are phase change ink compositions comprising a colorant and a phase change ink carrier comprising a material of this formula.

Copending application U.S. Ser. No. 10/235,109, filed Sep. 4, 2002, U.S. Publication 20040075723, and Copending application U.S. Ser. No. 10/810,370, filed Mar. 26, 2004, both entitled “Alkylated Urea and Triaminotriazine Compounds and Phase Change Inks Containing Same,” with the named inventors Marcel P. Breton, Danielle C. Boils-Boissier, Jule W. Thomas, Jr., Donald R. Tifterington, H. Bruce Goodbrand, Jeffery H. Banning, James D. Wuest, Dominic Laliberte, and Marie-Eve Perron, the disclosure of which is totally incorporated herein by reference, discloses compounds of the formulae

wherein Z is a group of the formula —OR₁, a group of the formula —SR₁, or a group of the formula —NR₁R₂, Y is a group of the formula —OR₃, a group of the formula —SR₃, or a group of the formula —NR₃R₄, n is an integer representing the number of repeat —(CH₂)— or —(CH₂CH₂O)— units, wherein, provided that at least one of R₁, R₂, R₃, R₄, R₅, and R₆ is a hydrogen atom, provided that at least one of R₁, R₂, R₃, R₄, R₅, and R₆ is other than a hydrogen atom, and provided that at least one Z or Y within the compound is a group of the formula —NR₁R₂ or a group of the formula —NR₃R₄, R₁, R₂, R₃, R₄, R₅, R₆, and R₇ each, independently of the others, is (i) a hydrogen atom, (ii) an alkyl group, (iii) an aryl group, (iv) an arylalkyl group, or (v) an alkylaryl group, and wherein R₇ can also be (vi) an alkoxy group, (vii) an aryloxy group, (viii) an arylalkyloxy group, (ix) an alkylaryloxy group, (x) a polyalkyleneoxy group, (xi) a polyaryleneoxy group, (xii) a polyarylalkyleneoxy group, (xiii) a polyalkylaryleneoxy group, (xiv) a silyl group, (xv) a siloxane group, (xvi) a polysilylene group, (xvii) a polysiloxane group, or (xviii) a group of the formula

wherein r is an integer representing a number of repeat —CH₂— groups, wherein s is an integer representing a number of repeating —CH₂— groups, and wherein X is (a) a direct bond, (b) an oxygen atom, (c) a sulfur atom, (d) a group of the formula —NR₄₀— wherein R₄₀ is a hydrogen atom, an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, or (e) a group of the formula —CR₅₀R₆₀— wherein R₅₀ and R₆₀ each, independently of the other, is a hydrogen atom, an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, and wherein R₆ can also be

Also disclosed are phase change ink compositions comprising a colorant and a phase change ink carrier comprising a material of this formula.

Copending application U.S. Ser. No. 10/235,125, filed Sep. 4, 2002, U.S. Publication 20040065227, entitled “Phase Change Inks Containing Gelator Additives,” with the named inventors Marcel P. Breton, Danielle C. Boils-Boissier, Donald R. Titterington, Jule W. Thomas, Jr., Jeffery H. Banning, Christy Bedford, and James D. Wuest, the disclosure of which is totally incorporated herein by reference, discloses a phase change ink composition comprising an ink vehicle, a colorant, and a nonpolymeric organic gelator selected from the group consisting of anthracene-based compounds, steroid compounds, partially fluorinated high molecular weight alkanes, high molecular weight alkanes with exactly one hetero atom, chiral tartrate compounds, chiral butenolide-based compounds, bis-urea compounds, guanines, barbiturates, oxamide compounds, ureidopyrimidone compounds, and mixtures thereof, said organic gelator being present in the ink in an amount of no more than about 20 percent by weight of the ink, said ink having a melting point at or below which the ink is a solid, said ink having a gel point at or above which the ink is a liquid, and said ink exhibiting a gel state between the melting point and the gel point, said ink exhibiting reversible transitions between the solid state and the gel state upon heating and cooling, said ink exhibiting reversible transitions between the gel state and the liquid state upon heating and cooling, said melting point being greater than about 35° C., said gel point being greater than said melting point. Also disclosed are imaging processes employing phase change inks containing gelator additives.

BACKGROUND

Disclosed herein are curable trans-1,2-cyclohexane bis(urea-urethane) compounds. More specifically, disclosed herein are some curable trans-1,2-cyclohexane bis(urea-urethane) compounds and hot melt or phase change inks containing these compounds. One embodiment is directed to curable trans-1,2-cyclohexane bis(urea-urethane) compounds of the formulae

wherein R₁ and R′₁ each, independently of the other, is an alkylene group, an arylene group, an arylalkylene group, or an alkylarylene group, R₂ and R′₂ each, independently of the other, is an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, R₃ and R′₃ each, independently of the other, is a hydrogen atom or an alkyl group, R₄ and R′₄ each, independently of the other, is a hydrogen atom, a fluorine atom, an alkyl group, or a phenyl group, n is an integer of 0, 1, 2, 3, or 4, and R₅ is an alkyl group, an aryl group, an arylalkyl group, an alkylaryl group, or a substituent other than an alkyl, aryl, arylalkyl, or alkylaryl group, provided that at least one of R₁, R′₁, R₂, R′₂, R₃, R′₃, R₄, R′₄, or one or more of R₅ is an alkyl, alkylene, arylalkyl, arylalkylene, alkylaryl, or alkylarylene group containing an ethylenic unsaturation rendering the compound curable upon exposure to heat and/or actinic radiation.

In general, phase change inks (sometimes referred to as “hot melt inks”) are in the solid phase at ambient temperature, but exist in the liquid phase at the elevated operating temperature of an ink jet printing device. At the jet operating temperature, droplets of liquid ink are ejected from the printing device and, when the ink droplets contact the surface of the recording substrate, either directly or via an intermediate heated transfer belt or drum, they quickly solidify to form a predetermined pattern of solidified ink drops. Phase change inks have also been used in other printing technologies, such as gravure printing, as disclosed in, for example, U.S. Pat. No. 5,496,879 and German Patent Publications DE 4205636AL and DE 4205713AL, the disclosures of each of which are totally incorporated herein by reference.

Phase change inks for color printing typically comprise a phase change ink carrier composition which is combined with a phase change ink compatible colorant. In a specific embodiment, a series of colored phase change inks can be formed by combining ink carrier compositions with compatible subtractive primary colorants. The subtractive primary colored phase change inks can comprise four component dyes, namely, cyan, magenta, yellow and black, although the inks are not limited to these four colors. These subtractive primary colored inks can be formed by using a single dye or a mixture of dyes. For example, magenta can be obtained by using a mixture of Solvent Red Dyes or a composite black can be obtained by mixing several dyes. U.S. Pat. No. 4,889,560, U.S. Pat. No. 4,889,761, and U.S. Pat. No. 5,372,852, the disclosures of each of which are totally incorporated herein by reference, teach that the subtractive primary colorants employed can comprise dyes from the classes of Color Index (C.I.) Solvent Dyes, Disperse Dyes, modified Acid and Direct Dyes, and Basic Dyes. The colorants can also include pigments, as disclosed in, for example, U.S. Pat. No. 5,221,335, the disclosure of which is totally incorporated herein by reference. U.S. Pat. No. 5,621,022, the disclosure of which is totally incorporated herein by reference, discloses the use of a specific class of polymeric dyes in phase change ink compositions.

Phase change inks have also been used for applications such as postal marking, industrial marking, and labelling.

Phase change inks are desirable for ink jet printers because they remain in a solid phase at room temperature during shipping, long term storage, and the like. In addition, the problems associated with nozzle clogging as a result of ink evaporation with liquid ink jet inks are largely eliminated, thereby improving the reliability of the ink jet printing. Further, in phase change ink jet printers wherein the ink droplets are applied directly onto the final recording substrate (for example, paper, transparency material, and the like), the droplets solidify immediately upon contact with the substrate, so that migration of ink along the printing medium is prevented and dot quality is improved.

Compositions suitable for use as phase change ink carrier compositions are known. Some representative examples of references disclosing such materials include U.S. Pat. No. 3,653,932, U.S. Pat. No. 4,390,369, U.S. Pat. No. 4,484,948, U.S. Pat. No. 4,684,956, U.S. Pat. No. 4,851,045, U.S. Pat. No. 4,889,560, U.S. Pat. No. 5,006,170, U.S. Pat. No. 5,151,120, U.S. Pat. No. 5,372,852, U.S. Pat. No. 5,496,879, European Patent Publication 0187352, European Patent Publication 0206286, German Patent Publication DE 4205636AL, German Patent Publication DE 4205713AL, and PCT Patent Application WO 94/04619, the disclosures of each of which are totally incorporated herein by reference. Suitable carrier materials can include paraffins, microcrystalline waxes, polyethylene waxes, ester waxes, fatty acids and other waxy materials, fatty amide containing materials, sulfonamide materials, resinous materials made from different natural sources (tall oil rosins and rosin esters, for example), and many synthetic resins, oligomers, polymers, and copolymers.

U.S. Pat. No. 6,761,758 (Boils-Boissier et al.), the disclosure of which is totally incorporated herein by reference, discloses compounds of the formulae

wherein, provided that at least one of R₁, R₂, R₃, R₄, R₅, and R₆ is a hydrogen, atom, and provided that at least one of R₁, R₂, R₃, R_(4,) R₅, and R₆ is not a hydrogen atom, R₁, R₂, R₃, R₄, R₅, and R₆ each, independently of the others, is (i) a hydrogen atom, (ii) an alkyl group, (iii) an aryl group, (iv) an arylalkyl group, or (v) an alkylaryl group. Also disclosed are phase change ink compositions comprising a colorant and a phase change ink carrier comprising a material of this formula.

U.S. Pat. No. 6,471,758 and European Patent Publication EP 1 067 157 (Kelderman et al.), the disclosures of each of which are totally incorporated herein by reference, disclose an ink composition for a meltable ink usable in a printing device in which ink drops are ejected from ink ducts, which comprises agents which reversibly cross-link the ink, the said agents containing a gelling agent. When an ink drop which has been transferred to a substrate passes over into a gel during the cooling process, the consequence is that the viscosity of the melted ink drop increases greatly so that the drops become relatively immobile. In this way the ink drops are prevented from uncontrollably flowing into the paper. As a result, inks of this kind are suitable for use on both porous and smooth substrates. In addition, these inks have been found suitable for use in a printing device in which printed substrates are subjected to thermal after-treatment.

“Cyclic Bis-Urea Compounds as Gelators for Organic Solvents,” J. van Esch et al., Chem. Eur. J. 1999, 5, No. 3, pp. 937-950, the disclosure of which is totally incorporated herein by reference, discloses the study of the gelation properties of bis-urea compounds derived from optically pure trans-1,2-diaminocyclohexane and 1,2-diaminobenzene, with pendant aliphatic, aromatic, or ester groups, as well as the structure of the resulting gels.

“The Design of Organic Gelators Based on a Family of Bis-Ureas,” R. E. Melendez et al., Mat. Res. Soc. Symp. Proc. 2000, 604, pp. 335-340, the disclosure of which is totally incorporated herein by reference, discloses a study of the organogelation properties of a family of bis-ureas.

“Formation of Organogels by Intermolecular Hydrogen Bonding Between Ureylene Segment,” K. Hanabusa et al., Chem. Lett. 1996 pp. 885-886, the disclosure of which is totally incorporated herein by reference, discloses low molecular weight compounds having ureylene segment causing physical gelation in organic solvents. The main driving force for gelation was intermolecular hydrogen bonding between ureylene units.

“Low Molecular Weight Gelators for Organic Solvents,” J. van Esch et al., in Supromolecular Science: Where Is It and Where It Is Going, R. Ungaro and E. Dalcanale, Eds., 1999, Netherlands: Kluwer Academic Publishers, pp. 233-259, the disclosure of which is totally incorporated herein by reference, discloses the gelation of solvents by organogelators.

“Organogels and Low Molecular Mass Organic Gelators,” D. J. Abdallah and R. G. Weiss, Adv. Mater. 2000, 12, No. 17, September 1, pp. 1237-1247, the disclosure of which is totally incorporated herein by reference, discloses the stepwise simplification of low molecular-mass organic gelator structures and the development of methods to determine their packing in organogels at the micrometer-to-angstrom distance regimes, as well as an overview of current and potential applications for these materials.

“Remarkable Stabilization of Self-Assembled Organogels by Polymerization,” M. de Loos et al., J. Am. Chem. Soc. 1997, 119, 12675-12676, the disclosure of which is totally incorporated herein by reference, discloses studies of polymerizable bis(amido)cyclohexane and bis(ureido)cyclohexane derivatives, investigating their gelating capacity for organic solvents.

“Low-molecular weight organogelators,” P. Terech, in Specialist Surfactants, I. D. Robb, Ed., 1997, London: Chapman & Hall, pp. 208-68, the disclosure of which is totally incorporated herein by reference, discloses a special class of surfactants which have the ability to form viscoelastic fluids or solid-like materials in organic solvents at concentrations lower than about 2 percent.

“New Functional Materials Based on Self-Assembling Organogels: From Serendipity Towards Design,” J. H. van Esch and B. L. Feringa, Angew. Chem. Int. Ed. 2000, 39, No. 13, pp. 2263-2266, the disclosure of which is totally incorporated herein by reference, discloses a review of developments in the field of organogels.

“Synthesis and Self-Assembling Properties of Polymerizable Organogelators,” G. Wang and A. D. Hamilton, Chem. Eur. J. 2002, 8, No. 8, pp. 1954-1961, the disclosure of which is totally incorporated herein by reference, discloses the development of a family of polymerizable urea derivatives that are gelators for organic solvents.

“Low Molecular Mass Gelators of Organic Liquids and the Properties of their Gels,” P. Terech and R. G. Weiss, Chem. Rev. 1997, 97, pp. 3133-3159, the disclosure of which is totally incorporated herein by reference, discloses a review of the properties of thermally-reversible viscoelastic liquidlike or solidlike organogels comprising an organic liquid and low concentrations of relatively low molecular mass gelator molecules.

“Towards a Phenomenological Definition of the Term ‘Gel’,” K. Amdal et al., Polymer Gels and Networks, 1993, 1, pp. 5-17, the disclosure of which is totally incorporated herein by reference, discusses existing definitions of the term “gel” and proposes specific uses of the term.

PCT Patent Publication WO 03/084508 and European Patent Publication EP 1 350 507 (Friesen et al.), the disclosures of each of which are totally incorporated herein by reference, disclose delivery vehicles for delivering a substance of interest to a predetermined site, said vehicle comprising said substance and a means for inducing availability of at least one compartment of said vehicle toward the exterior, thereby allowing access of said substance to the exterior of said vehicle at said predetermined site. The invention is further concerned with uses of said vehicle and methods for preparing it.

PTC Patent Publication WO 03/040135 (Dowle et al.), the disclosure of which is totally incorporated herein by reference, discloses compounds of the formula

in which R is an amino or guanidino group, R₂ is acetyl or trifluoroacetyl, X is CONH, SO₂NH, NHCO, or NHCONH, m is either 0 or 1, n is an integer from 2 to 6, q is an integer from 0 to 3, and Y is hydrogen or an aromatic substituent, or a pharmaceutically acceptable derivative thereof. Also disclosed are methods for their preparation, pharmaceutical formulations containing them, and their use in the prevention or treatment of a viral infection.

PTC Patent Publication WO 00/55149 and U.S. Pat. No. 6,548,476 (Wu et al.), the disclosures of each of which are totally incorporated herein by reference, disclose dimeric compounds, methods for their preparation, pharmaceutical formulations thereof, and their use as antiviral agents. The compounds are particularly useful against influenza virus. In particular the references disclose a dimeric compound which comprises two neuraminidase binding groups attached to a spacer or linking group. Preferably the dimeric molecule comprises two neuraminidase-binding neuraminic acid (sialic acid) or cyclopentyl or cyclohexenyl carboxylic acid derivatives covalently attached to a common spacer group. Pharmaceutical compositions and methods of treatment, prophylaxis and diagnosis are disclosed and claimed.

U.S. Patent Publication 20010044553 (Kabashima et al.), the disclosure of which is totally incorporated herein by reference, discloses a urea-urethane compound having one or more urea groups and one or more urethane groups in the molecular structure, the number of said urea groups (A) and the number of said urethane groups (B) satisfying the following numerical formula: 10≧(A+B)≧3 wherein each of A and B is an integer of 1 or more.

European Patent Publication EP 1 048 681 and U.S. Pat. No. 6,420,466 (Haubennestel et al.), the disclosures of each of which are totally incorporated herein by reference, disclose a process for preparing a solution that is active as a thixotropic agent and contains urea urethanes, in which monohydroxyl compounds are reacted with an excess of toluene diisocyanate, the unreacted portion of the toluene diisocyanate is removed from the reaction mixture, and the monosiocyanate adduct obtained is further reacted with diarines in the presence of a lithium salt to form urea urethanes. The invention also relates to the use of the solution for imparting thixotropic properties to coating compounds.

Japanese Patent Publication JP 10310633, the disclosure of which is totally incorporated herein by reference, discloses a cationic curing catalyst composition improved in stability during storage at room temperature or above and suppressed in increase in viscosity, using at least one stabilizer selected from the compounds containing a urethane bond, an amide bond, a urea bond and a carbodiimide group in the molecule and a dialkylaminopyridine compound or a proton acid compound.

European Patent Publication EP 0 056 153 and U.S. Pat. No. 4,384,102 (Rasshofer et al.), the disclosures of each of which are totally incorporated herein by reference, disclose compounds having both s-triazine units and epoxide groups present that are prepared by reacting an epoxide containing an isocyanate-reactive group with a triisocyanate corresponding to the formula

in which X is as defined therein. These reactants are used in quantities such that the equivalent ratio of isocyanate groups to isocyanate-reactive groups is maintained at less than or equal to 1 to 1. The compounds thus produced are particularly useful as reactive cross-linkers in the production of polyurethanes and polyepoxides.

European Patent Publication EP 0 160402 and U.S. Pat. No. 4,566,981 (Howells), the disclosures of each of which are totally incorporated herein by reference, disclose cationic and non-ionic fluorochemicals, mixtures of cationic and non-ionic fluorochemicals, blends of the mixtures with fluorochemical poly(oxyalkylenes), and compositions of the fluorochemicals with hydrocarbon nonionic surfactants. These fluorochemicals and compositions, in dispersions, emulsions and microemulsions, may be applied to porous fibrous substrates to give oil and water repellency and soil resistance.

Japanese Patent Publication JP 59030919, the disclosure of which is totally incorporated herein by reference, discloses a method to prevent the bad influence of a treatment on spinning properties and drawing properties of synthetic yarn, by providing undrawn yarn of melt spinning with a spinning oil, applying a specific treatment to it, drawing and heat-treating it. The undrawn yarn which is prepared by melt spinning and cooled is provided with a spinning oil by the oil applicator, coated with a treatment by the treatment applicator, sent through the taking up roller and the drawing rollers, and wound around the winder. The treatment is a compound shown by the formula (R_(f)-A-B₁—CONH—X—NHCO—B₂—)_(n)Y (R_(f) is 4-16C perfluoroalkyl; A is —(CH₂)_(x1)—, CON(R₁)—(CH₂)_(x2)—, or SO₂N(R₁)—(CH₂)_(x2)—; x1 is 1-20 integer; x2 is 1-12 integer; R₁ is H, or 1-6C alkyl; B₁ and B₂ are —O—, —S—, or —N(R₂)—; R₂ is H, or 1-4C alkyl; X is bifunctional organic group; Y is polyfunctional organic group; n is 2-10 integer) and its pickup is 0.03-2.0 wt %.

Compounds that enable gelation are also disclosed in, for example: “Reversible Polymers Formed from Self-Complementary Monomers Using Quadruple Hydrogen Bonding,” R. P. Sijbesma et al., Science, Vol. 278, p. 1601 (1997); “Supramolecular Polymers,” R. Dagani, Chemical and Engineering News, p. 4 (December 1997); “Supramolecular Polymers from Linear Telechelic Siloxanes with Quadruple-Hydrogen-Bonded Units,” J. H. K. Hirschberg et al., Macromolecules, Vol. 32, p. 2696 (1999); “Design and Synthesis of ‘Smart’ Supramolecular Liquid Crystalline Polymers via Hydrogen-Bond Associations,” A. C. Griffin et al., PMSE Proceedings, Vol. 72, p. 172 (1995); “The Design of Organic Gelators: Solution and Solid State Properties of a Family of Bis-Ureas,” Andrew J. Carr et al., Tetrahedron Letters, Vol. 39, p. 7447 (1998); “Hydrogen-Bonded Supramolecular Polymer Networks,” Ronald F. M. Lange et al., Journal of Polymer Science, Part A: Polymer Chemistry, Vol. 37, p. 3657 (1999); “Combining Self-Assembly and Self-Association—Towards Columnar Supramolecular Structures in Solution and in Liquid-Crystalline Mesophase,” Arno Kraft et al., Polym. Mater. Sci. Eng., Vol. 80, p. 18 (1999); “Facile Synthesis of β-Keto Esters from Methyl Acetoacetate and Acid Chloride: The Barium Oxide/Methanol System,” Y. Yuasa et al., Organic Process Research and Development, Vol. 2, p. 412 (1998); “Self-Complementary Hydrogen Bonding of 1,1′-Bicyclohexylidene-4,4′-dione Dioxime. Formation of a Non-Covalent Polymer,” F. Hoogesteger et al., Tetrahedron, Vol. 52, No. 5, p. 1773 (1996); “Molecular Tectonics. Three-Dimensional Organic Networks with Zeolite Properties,” X. Wang et al., J. Am. Chem. Soc., Vol. 116, p. 12119 (1994); “Helical Self-Assembled Polymers from Cooperative Stacking of Hydrogen-Bonded Pairs,” J. H. K. Ky Hirschberg et al., Nature, Vol. 407, p. 167 (2000); “New Supramolecular Arrays based on Interactions between Carboxylate and Urea Groups: Solid-State and Solution Behavior,” Abdullah Zafar et al., New J. Chem., 1998, 137-141; U.S. Pat. No. 6,320,018; U.S. Pat. No. 5,892,116; PCT Patent Publication WO 97/24364; “The Unusual Molecular Organization of 2,3-Bis(n-hexyloxy)-anthracene in the Crystal. A Hint to the Origin of the Gelifying Properties of 2,3-Bis(n-alkyloxy)anthracenes?”, J-L. Pozzo et al., J. Chem. Soc., Perkin Trans., 2, 824-826 (2001); “The Quest for the Simplest Possible Organogelators and Some Properties of their Organogels,” D. Abdallah et al., J. Braz. Chem. Soc., Vol. 11, No. 3, 209-218 (2000); “Organogel Electrolytes Based on a Low Molecular Weight Gelator: 2,3-Bis(n-decyloxy)anthracene,” F. Placin et al., Chem. Mater. 13, 117-121 (2001); “Novel Vesicular Aggregates of Crown-Appended Cholesterol Derivatives Which Act as Gelators of Organic Solvents and as Templates for Silica Transcription,” J. Jung et al., J. Am. Chem. Soc., Vol. 122, No. 36, 8648-8653 (2000); “n-Alkanes Gel n-Alkanes (and Many Other Organic Liquids),” D. Abdallah et al., Langmuir, 16, 352-355 (2000); “Low Molecular Mass Gelators of Organic Liquids and the Properties of their Gels,” P. Terech et al., Chem. Rev., 97, 3133-3159 (1997); “Organogels and Low Molecular Mass Organic Gelators,” D. Abdallah et al., Adv. Mater., 12, No. 17, 1237 (2000); “Making it All Stick Together: the Gelation of Organic Liquids by Small Organic Molecules,” F. Schoonbeek, Doctoral Thesis, U. of Groningen, Netherlands, April 2001; Twieg et al., Macromolecules, Vol. 18, p. 1361 (1985); “Synthesis and Reactions of Polyhydric Alcohols I. Synthesis and Reactions of p-Toluenesulfonates of Polyhydric Alcohols,” Zhurnal Obshchei Khimii, Vol. 35, No. 5, p. 804-807 (1965); “The Chemotherapy of Schistosomiasis. Part I. Derivatives and Analogs of αω-Di-(p-aminophenoxy)alkanes,” J. Ashley et al., J. Chem. Soc. 1958, 3293; “Remarkably Simple Small Organogelators: Di-n-alkoxy-benzene Derivatives,” G. Clavier et al., Tetrahedron Letters, 40, 9021-9024 (1999); “Rational Design of Low Molecular Mass Organogelators: Toward a Library of Functional N-Acyl-1-ω-Amino Acid Derivatives,” G. Mieden-Gundert et al., Angew. Chem. Int. Ed., 40, No. 17, 3164-3166 (2001); U.S. Pat. No. 2,703,808; “Rational Design of New Acid-Sensitive Organogelators,” J-L. Pozzo et al., J. Mater. Chem., Vol. 8, pp. 2575-2577 (1998); J. T. Thurston et al., J. Am. Chem. Soc., Vol. 73, pp. 2981-3008 (1951); J. Am. Chem. Soc., Vol. 96, pp. 1082-1087 (1974); J-L. Pozzo et al., Tetrahedron, Vol. 53, No. 18, pp. 6377-6390 (1997); J-L. Pozzo et al., Mol. Cryst. Liq. Cryst., Vol. 344, pp. 101 -106 (2000); Y. C. Lin, R. G. Weiss, Macromolecules, Vol. 20, p. 414 (1987); U.S. Pat. No. 4,790,961; Murata et al, J. Am. Chem. Soc., Vol. 116, No 15, pp. 6664-6676 (1994); A. Ikeda et al., Rep. Asahi Glass Found. Ind. Technol., Vol. 61, p. 115, (1992); Rabolt et al., Macromolecules, Vol. 17, p. 2786 (1984); D. J. Abdallah et al., Chem. Mater., Vol. 11, p. 2907 (1999); Ralston et al., J. Org. Chem., Vol. 9, p. 259 (1944); L. Lu et al., Chem. Commun., 1996, p. 2029; J. Prakt. Chem., Vol. 327 (3), pp. 383-98 (1985); B. L. Feringa et al., J. Org. Chem., Vol. 53, p. 1125 (1988); J. C. DeJong et al., Tetrahedron Lett., Vol. 30, p. 7239 (1989); J. C. DeJong, Ph.D. thesis, University of Groningen, The Netherlands, 1991; F. A. Neugebauer et al., Chem. Ber., 1976, 109, 2389; U. Zehavi et al., J. Org. Chem., Vol. 26, pp. 1097-1101 (1961); J. March, Advanced Organic Chemistry, 4^(th) Edition, pp. 903 and 1091-1092, Wiley Interscience (New York 1992); J. Crossley Maxwell, Aust. J. Chem., Vol. 47, pp. 723-738 (1994); V. J. Wotring et al., Analytical Chemistry, Vol. 62, No. 14, pp. 1506-1510 (1990); Tabushi et al., J. Am. Chem. Soc., Vol. 103, pp. 6152-6157 (1981); T. Giorgi et al., “Gel-like lyomesophases formed in organic solvents by self-assembled guanine ribbons,” Chemistry—A European Journal (2002), 8(9), 2143-2152; T. Suyama et al., “A method for the preparation of substituted biguanides,” Nippon Kagaku Kaishi (1989), (5), 884-7; Polish Patent Publication PL 148060 B1; Polish Patent Publication PL 134682 B1; C. S. Snijder et al., Chem. Eur. J., Vol. 1, No. 9, pp. 594-597 (1995); S. Senda et al., Gifu Coll. Pharm., Gifu, Japan. Yakugaku Zasshi (1969), 89 (2), 254-259; B. Gluncic et al, Acta Phorm. Jugosl. (1986), 36(4), 393-404; Canadian Patent Publication CA 941377; M. Klein, Recent Dev. Mass Spectrom. Biochem. Med., (Proc. Int. Symp.), 4^(th) (1978), Meeting Date 1977, 1, 471-82; PCT Patent Publication WO/9011283; Japanese Patent Publication JP 62181279; T. Wada et al., “A New Boranophosphorylation Reaction for the Synthesis of Deoxyribonucleoside Boranophosphates,” Tetrahedron Letters, Vol. 43, No. 23, pp. 4137-4140 (2002); R. Schirrmacher et al., “Dimethylpyridin-4-ylamine-catalysed alcoholysis of 2-amino-N,N,N-trimethyl-9H-purine-6-ylammonium chloride: An effective route to O6-substituted guanine derivatives from alcohols with poor nucleophilicity,” Synthesis, Vol. 4, pp. 538-542 (2002); Z. Situ, “Synthesis of Tricyclic Derivatives of Guanine Analogue Catalyzed by KF—Al₂O₃ ,” Huaxue Shiji, Vol. 24, No. 1, p. 57 (2002); Korean Patent 2000003081 (Korean Patent Application KR 1998-24185); S. Bailey et al., “Synthesis and Antiviral Activity of 9-Alkoxypurines: New 9-(Hydroxyalkoxy) Derivatives of Guanine and 8-Methylguanine,” Antiviral Chem. Chemother., Vol. 5, No. 1, pp. 21-33 (1994); Japanese Patent Publication JP 06157529; Japanese Patent Publication JP 3217541; M. R. Harnden et al., “Synthesis, Oral Bioavailability and In Vivo Activity of Acetal Derivatives of the Selective Antiherpesvirus Agent 9-(3-Hydroxypropoxy)Guanine (BRL44385),” Antiviral Chem. Chemother., Vol. 5, No. 3, pp. 147-54 (1994); Spanish Patent Publication ES 2047457; B. K. Bhattacharya et al., “Synthesis of Certain N— and C-alkyl Purine Analogs,” J. Heterocycl. Chem., Vol. 30, No. 5, pp. 1341-9 (1993); Polish Patent Publication PL 148969; PCT Patent Publication WO/9011283; U.S. Pat. No. 5,298,618; and Japanese Patent Publication JP 62181279, the disclosures of each of which are totally incorporated herein by reference.

U.S. Pat. No. 6,586,492 and PCT Patent Publication WO 99/54416 (Caiger et al.), the disclosures of each of which are totally incorporated herein by reference, disclose an ink-jet ink including an ink jet vehicle and a colorant. The vehicle includes at least 35 percent by weight radiation curable material, based on the total vehicle weight. The vehicle may but does not necessarily include a thickener. The vehicle is a paste or a solid at 20° C. and has a viscosity of less than 25 centipoise between 40° C. and 130° C.

Japanese Patent Publication JP 6200204, the disclosure of which is totally incorporated herein by reference, discloses a normally solid jet recording ink which can melt at a relatively low temperature and can cure immediately when irradiated with ultraviolet rays. The ink comprises a wax having a melting point of 40 to 70° C., a resin having a melting point of 40 to 70° C., a prepolymer, a monomer, a photopolymerization initiator, a dye, and a pigment. This ink is normally solid because it contains the above-specified wax. When the ultraviolet curable resin is irradiated with ultraviolet rays from an ultraviolet lamp, the ink can fix immediately and satisfactorily on plain paper or printing paper.

The trans-1,2-cyclohexane bis-urea organogelator compounds exhibit some disadvantages for performing in a phase-change solid ink vehicle, such as high melting point and high degree of crystallinity. In addition, these compounds are commonly prepared by the reaction of trans-1,2-diaminocyclohexane with two molar equivalents of a monofunctional isocyanate, and their large-scale commercial preparation is often limited to the use of available monofunctional isocyanate raw materials that are regulated for health and safety reasons.

Many currently used phase change inks require high jetting temperatures of about 140° C. or greater and also require relatively long warm-up times for the printer. In addition, many currently used phase change inks generate images with relatively poor scratch resistance and relatively poor image permanence.

While known compositions and processes are suitable for their intended purposes, a need remains for improved phase change ink compositions. In addition, a need remains for phase change inks that can be jetted at reduced temperatures of about 110° C. or lower, thereby enabling cost and energy savings. Further, a need remains for phase change inks that enable printing with reduced printer warm-up times. Additionally, a need remains for phase change inks that generate images with improved scratch resistance. There is also a need for phase change inks that generate images with improved image permanence. In addition, there is a need for phase change inks that generate images with improved image quality. Further, there is a need for phase change inks that exhibit the aforementioned advantages when used in a printing process wherein the ink is first jetted onto an intermediate transfer member and subsequently transferred from the intermediate transfer member to a final print substrate such as plain or coated paper or a transparency. Additionally, there is a need for phase change inks that exhibit the aforementioned advantages when used in a printing process wherein the ink is jetted directly onto a final print substrate such as plain or coated paper or a transparency. A need also remains for phase change inks that exhibit the aforementioned advantages when used in printing processes at relatively high speeds. In addition, a need remains for phase change inks having desirably low melting points that also contain gelator compounds which enable additional advantages in the phase change inks. Further, a need remains for gelator compounds for use in phase change inks and other applications that have a desirably low degree of crystallinity. Additionally, a need remains for gelator compounds that are soluble in phase change ink carriers. There is also a need for phase change inks that exhibit an intermediate gel phase between the solid phase and the liquid phase. In addition, there is a need for phase change inks exhibiting an intermediate gel phase wherein the gel phase transition is desirably narrow. Further, there is a need for gelator compounds that enable desirably narrow gel phase transitions. Additionally, there is a need for phase change inks exhibiting an intermediate gel phase wherein the gel phase transition entails a tan-delta of less than about 10. A need also remains for gelator compounds that enable gel phase transitions entailing a tan-delta of less than about 10. In addition, a need remains for gelator compounds that are less highly crystalline and do not pack as tightly within a molecular network as do more crystalline materials, thereby enabling them to be soluble within molten phase change inks. Additionally, a need remains for curable compounds that are soluble in phase change ink carriers. There is also a need for curable compounds that can be incorporated into phase change ink carriers without adversely affecting the viscosity characteristics of the ink at desired jetting temperatures. In addition, there is a need for curable compounds that can be incorporated into phase change ink carriers without adversely affecting the melting point of the ink. Further, there is a need for curable phase change inks that can be used in ink jet printing processes wherein the ink is first jetted onto an intermediate transfer member and subsequently transferred from the transfer member to a final substrate such as paper or transparency material. Additionally, there is a need for curable phase change inks that can be used in ink jet printing processes wherein the ink is first jetted onto an intermediate transfer member and subsequently transferred from the transfer member to a final substrate such as paper or transparency material, wherein the intermediate transfer member is maintained at a temperature between the jetting temperature of the ink and the temperature of the final substrate. A need also remains for curable compounds that can be incorporated into phase change ink carriers to be used in printing processes using heated intermediate transfer members without adversely affecting the temperature at which the intermediate transfer member can effectively transfuse the image thereon to the final substrate. In addition, a need remains for radiation curable compounds that undergo phase change transitions within a radiation-curable ink carrier. Further, a need remains for compounds that can impart phase change characteristics to a radiation curable ink and that are also themselves radiation curable. Additionally, a need remains for curable phase change inks that can be used in ink jet printing processes wherein the ink is jetted directly onto a final substrate such as uncoated paper and wherein the ink exhibits reduced feathering on the final substrate. There is also a need for curable phase change inks that can be used in ink jet printing processes wherein the ink is jetted directly onto a final substrate such as coated paper and wherein the image exhibits reduced pixel agglomeration on the final substrate.

SUMMARY

Disclosed herein are curable trans-1,2-cyclohexane bis(urea-urethane) compounds of the formulae

wherein R₁ and R′₁ each, independently of the other, is an alkylene group, an arylene group, an arylalkylene group, or an alkylarylene group, R₂ and R′₂ each, independently of the other, is an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, R₃ and R′₃ each, independently of the other, is a hydrogen atom or an alkyl group, R₄ and R′₄ each, independently of the other, is a hydrogen atom, a fluorine atom, an alkyl group, or a phenyl group, n is an integer of 0, 1, 2, 3, or 4, and R₅ is an alkyl group, an aryl group, an arylalkyl group, an alkylaryl group, or a substituent other than an alkyl, aryl, arylalkyl, or alkylaryl group, provided that at least one of R₁, R′₁, R₂, R′₂, R₃, R′₃, R₄, R′₄, or one or more of R₅ is an alkyl, alkylene, arylalkyl, arylalkylene, alkylaryl, or alkylarylene group containing an ethylenic unsaturation rendering the compound curable upon exposure to heat and/or actinic radiation.

DETAILED DESCRIPTION

The curable trans-1,2-cyclohexane bis(urea-urethane) compounds are of the formulae

wherein R₁ and R′₁ each, independently of the other, is (i) an alkylene group (including linear, branched, saturated, unsaturated, cyclic, substituted, and unsubstituted alkylene groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in the alkylene group), in one embodiment with at least about 2 carbon atoms, in another embodiment with at least about 4 carbon atoms, and in yet another embodiment with at least about 6 carbon atoms, and in one embodiment with no more than about 50 carbon atoms, in another embodiment with no more than about 30 carbon atoms, and in yet another embodiment with no more than about 20 carbon atoms, although the number of carbon atoms can be outside of these ranges, (ii) an arylene group (including substituted and unsubstituted arylene groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in the arylene group), in one embodiment with at least about 5 carbon atoms, and in another embodiment with at least about 6 carbon atoms, and in one embodiment with no more than about 18 carbon atoms, in another embodiment with no more than about 12 carbon atoms, and in yet another embodiment with no more than about 6 carbon atoms, although the number of carbon atoms can be outside of these ranges, (iii) an arylalkylene group (including substituted and unsubstituted arylalkylene groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in either the aryl or the alkyl portion of the arylalkylene group), in one embodiment with at least about 6 carbon atoms, and in another embodiment with at least about 7 carbon atoms, and in one embodiment with no more than about 50 carbon atoms, in another embodiment with no more than about 30 carbon atoms, and in yet another embodiment with no more than about 20 carbon atoms, although the number of carbon atoms can be outside of these ranges, such as benzylene or the like, including (a) arylalkylene groups wherein both the aryl and the alkyl portions form the linkage between the two —NH— groups, such as

and the like, and (b) arylalkylene groups wherein only the alkyl portion forms the linkage between the two —NH— groups, such as

and the like, or (iv) an alkylarylene group (including substituted and unsubstituted alkylarylene groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in either the aryl or the alkyl portion of the alkylarylene group), in one embodiment with at least about 6 carbon atoms, and in another embodiment with at least about 7 carbon atoms, and in one embodiment with no more than about 50 carbon atoms, in another embodiment with no more than about 30 carbon atoms, and in yet another embodiment with no more than about 20 carbon atoms, although the number of carbon atoms can be outside of these ranges, such as tolylene or the like, including (a) alkylarylene groups wherein both the alkyl and the aryl portions form the linkage between the two —NH— groups, such as

and the like, and (b) alkylarylene groups wherein only the aryl portion forms the linkage between the two —NH— groups, such as

and the like, R₂ and R′₂ each, independently of the other, is (i) an alkyl group (including linear, branched, saturated, unsaturated, cyclic, substituted, and unsubstituted alkyl groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in the alkyl group), in one embodiment with at least about 2 carbon atoms, in another embodiment with at least about 4 carbon atoms, and in yet another embodiment with at least about 6 carbon atoms, and in one embodiment with no more than about 50 carbon atoms, in another embodiment with no more than about 30 carbon atoms, and in yet another embodiment with no more than about 20 carbon atoms, although the number of carbon atoms can be outside of these ranges, (ii) an aryl group (including substituted and unsubstituted aryl groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in the aryl group), in one embodiment with at least about 5 carbon atoms, and in another embodiment with at least about 6 carbon atoms, and in one embodiment with no more than about 18 carbon atoms, in another embodiment with no more than about 12 carbon atoms, and in yet another embodiment with no more than about 6 carbon atoms, although the number of carbon atoms can be outside of these ranges, (iii) an arylalkyl group (including substituted and unsubstituted arylalkyl groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in either the aryl or the alkyl portion of the arylalkyl group), in one embodiment with at least about 6 carbon atoms, and in another embodiment with at least about 7 carbon atoms, and in one embodiment with no more than about 50 carbon atoms, in another embodiment with no more than about 30 carbon atoms, and in yet another embodiment with no more than about 20 carbon atoms, although the number of carbon atoms can be outside of these ranges, such as benzyl or the like, or (iv) an alkylaryl group (including substituted and unsubstituted alkylaryl groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in either the aryl or the alkyl portion of the alkylaryl group), in one embodiment with at least about 6 carbon atoms, and in another embodiment with at least about 7 carbon atoms, and in one embodiment with no more than about 50 carbon atoms, in another embodiment with no more than about 30 carbon atoms, and in yet another embodiment with no more than about 20 carbon atoms, although the number of carbon atoms can be outside of these ranges, such as tolyl or the like, R₃ and R′₃ each, independently of the other, is a hydrogen atom or an alkyl group (including linear, branched, substituted, and unsubstituted alkyl groups), in one embodiment with at least 1 carbon atom, and in one embodiment with no more than about 3 carbon atoms, although the number of carbon atoms can be outside of these ranges, R₄ and R′₄ each, independently of the other, is a hydrogen atom, a fluorine atom, an alkyl group (including linear, branched, saturated, unsaturated, substituted, and unsubstituted alkyl groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in the alkyl group), in one embodiment with at least 1 carbon atom, and in one embodiment with no more than about 6 carbon atoms, in another embodiment with no more than about 3 carbon atoms, and in yet another embodiment with no more than about 2 carbon atoms, although the number of carbon atoms can be outside of these ranges, or a phenyl group, n is an integer of 0, 1 2, 3, or 4, and each R₅, independently of the others, is (i) an alkyl group (including linear, branched, saturated, unsaturated, cyclic, substituted, and unsubstituted alkyl groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in the alkyl group), in one embodiment with at least 1 carbon atom, and in one embodiment with no more than about 50 carbon atoms, in another embodiment with no more than about 30 carbon atoms, and in yet another embodiment with no more than about 20 carbon atoms, although the number of carbon atoms can be outside of these ranges, (ii) an aryl group (including substituted and unsubstituted aryl groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in the aryl group), in one embodiment with at least about 5 carbon atoms, and in another embodiment with at least about 6 carbon atoms, and in one embodiment with no more than about 18 carbon atoms, in another embodiment with no more than about 12 carbon atoms, and in yet another embodiment with no more than about 6 carbon atoms, although the number of carbon atoms can be outside of these ranges, (iii) an arylalkyl group (including substituted and unsubstituted arylalkyl groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in either the aryl or the alkyl portion of the arylalkyl group), in one embodiment with at least about 6 carbon atoms, and in another embodiment with at least about 7 carbon atoms, and in one embodiment with no more than about 50 carbon atoms, in another embodiment with no more than about 30 carbon atoms, and in yet another embodiment with no more than about 20 carbon atoms, although the number of carbon atoms can be outside of these ranges, such as benzyl or the like, (iv) an alkylaryl group (including substituted and unsubstituted alkylaryl groups, and wherein hetero atoms, such as oxygen, nitrogen, sulfur, silicon, phosphorus, boron, and the like either may or may not be present in either the aryl or the alkyl portion of the alkylaryl group), in one embodiment with at least about 6 carbon atoms, and in another embodiment with at least about 7 carbon atoms, and in one embodiment with no more than about 50 carbon atoms, in another embodiment with no more than about 30 carbon atoms, and in yet another embodiment with no more than about 20 carbon atoms, although the number of carbon atoms can be outside of these ranges, such as tolyl or the like, or (v) a substituent other than an alkyl, aryl, arylalkyl, or alkylaryl group, wherein the substituents on the substituted alkyl, alkylene, aryl, arylene, arylalkyl, arylalkylene, alkylaryl, and alkylarylene groups for R₁, R′₁, R₂, R′₂, R₃, R′₃, R₄, R′₄, and R₅ and the substituents other than alkyl, aryl, arylalkyl, or alkylaryl groups can be (but are not limited to) halogen atoms, including fluorine, chlorine, bromine, and iodine atoms, imine groups, ammonium groups, cyano groups, pyridinium groups, ether groups, aldehyde groups, ketone groups, ester groups, carbonyl groups, thiocarbonyl groups, sulfide groups, sulfoxide groups, phosphine groups, nitrile groups, mercapto groups, nitro groups, nitroso groups, sulfone groups, acyl groups, urethane groups, urea groups, mixtures thereof, and the like, wherein two or more substituents can be joined together to form a ring.

Since hetero atoms can be included in the R₁ and R′₁ groups, R₁ and R′₁ also include alkyleneoxy, aryleneoxy, arylalkyleneoxy, alkylaryleneoxy, polyalkyleneoxy, alkoxyalkylene, alkoxyarylene, pyrrolidine, imidazole, pyrimidinone, oxazoline, thiazoline, and like groups, provided that no oxygen atom is directly bonded to one of the nitrogen atoms. In addition, since hetero atoms can be included in the R₁ and R′₁ groups, R₁ and R′₁ also include heterocyclic groups.

Since hetero atoms can be included in the R₂ and R′₂ groups, R₂ and R′₂ also include alkoxy, aryloxy, arylalkoxy, alkylaryloxy, polyalkyleneoxy, alkoxyalkyl, alkoxyaryl, pyrrolidine, imidazole, pyrimidinone, oxazoline, thiazoline, and like groups, provided that no oxygen atom is directly bonded to one of the nitrogen atoms. In addition, since hetero atoms can be included in the R₂ and R′₂ groups, R₂ and R′₂ also include heterocyclic groups.

Since hetero atoms can be included in the R₅ groups, these groups also include alkoxy, aryloxy, arylalkoxy, alkylaryloxy, polyalkyleneoxy, alkoxyalkyl, alkoxyaryl, pyrrolidine, imidazole, pyrimidinone, oxazoline, thiazoline, and like groups. In addition, since hetero atoms can be included in the R₅ groups, these groups also include heterocyclic groups.

In one specific instance, R₁ and R′₁ have in one embodiment at least about 2 carbon atoms, in another embodiment at least about 4 carbon atoms, and in yet another embodiment at least about 6 carbon atoms, although the number of carbon atoms can be outside of these ranges.

In one specific instance, R₁ and R′₁ have in one embodiment no more than about 30 carbon atoms, in another embodiment no more than about 18 carbon atoms, and in yet another embodiment no more than about 12 carbon atoms, although the number of carbon atoms can be outside of these ranges.

In one specific instance, R₂ and R′₂ have in one embodiment at least about 4 carbon atoms, in another embodiment at least about 5 carbon atoms, and in yet another embodiment at least about 6 carbon atoms, although the number of carbon atoms can be outside of these ranges.

In one specific instance, R₂ and R′₂ have in one embodiment no more than about 30 carbon atoms, in another embodiment no more than about 18 carbon atoms, and in yet another embodiment no more than about 12 carbon atoms, although the number of carbon atoms can be outside of these ranges.

At least one of R₁, R′₁, R₂, R′₂, R₃, R′₃, R₄, R′₄, and one or more of R₅ is an alkyl, alkylene, arylalkyl, arylalkylene, alkylaryl, or alkylarylene group containing an ethylenic unsaturation rendering the compound curable upon exposure to heat or actinic radiation. Examples of ethylenically unsaturated groups include (but are not limited to) alkene groups, vinyl ether groups, allyl ether groups, acrylate groups, methacrylate groups, acrylamide groups, methacrylamide groups, norbornenyl groups, isoprenyl groups, vinyl benzoate groups, vinyl ester groups, and the like. Curing can be initiated by any desired or effective mechanism, such as free radical, cationic, thermal, or the like.

By “curable upon exposure to heat and/or actinic radiation” is meant that the compound, upon exposure to heat and/or actinic radiation, reacts to convert ethylenically unsaturated carbon-to-carbon bonds to saturated carbon-carbon single covalent bonds, thereby undergoing crosslinking or chain extension. In many cases, the cured material can exhibit improved mechanical properties, such as greater mechanical strength, reduced solubility in solvents, and greater adhesion to substrates. Actinic radiation can be defined as radiation at wavelengths of from about 4 to about 500 nanometers. In a specific embodiment, the radiation is at wavelengths of from about 260 to about 440 nanometers. Heat curing can occur by any desired or effective mechanism, such as by the effect of heat upon an initiator molecule at any desired or effective temperature, in one embodiment from about 30° C. to about 150° C., and in another embodiment from about 60° C. to about 130° C., although the temperature can be outside of these ranges.

In one specific embodiment, R₁ and R′₁ are the same. In another specific embodiment, R₁ and R′₁ are the same and R₂ and R′₂ are the same. In yet another specific embodiment, R₁ and R′₁ are the same, R₂ and R′₂ are the same, R₃ and R′₃ are the same, and R₄ and R′₄ are the same. In still another specific embodiment, R₁ and R′₁ are the same, R₂ and R′₂ are the same, R₃ and R′₃ are the same, R₄ and R′₄ are the same, and n is 0. In another specific embodiment, R₁ and R′₁ are the same, R₂ and R′₂ are the same, R₃ and R′₃ are both hydrogen, R₄ and R′₄ are both hydrogen, and n is 0.

The trans-1,2-cyclohexane bis(urea-urethane) compounds can be prepared by any desired or effective method. For example, a monoalcohol of the formula R₂—OH can be reacted with a diisocyanate of the formula OCN—R₁—NCO in approximately equimolar amounts at elevated temperatures, optionally in the presence of a catalyst, and optionally in the presence of a solvent. Thereafter, the resulting product can be cooled to about room temperature and reacted with about 2 moles of product per every 1 mole of 1,2-diaminocyclohexane substituted as desired, optionally in the presence of a solvent, at room temperature. The reaction proceeds as follows (shown below without representing the stereochemistry; the asterisks indicate the chiral centers):

The monoalcohol and the diisocyanate are present in any desired or effective relative amounts, in one embodiment at least about 0.4 mole of monoalcohol per every one mole of diisocyanate, in another embodiment at least about 0.6 mole of monoalcohol per every one mole of diisocyanate, and in yet another embodiment at least about 0.8 mole of monoalcohol per every one mole of diisocyanate, and in one embodiment no more than about 1.4 moles of monoalcohol per every one mole of diisocyanate, in another embodiment no more than about 1.2 moles of monoalcohol per every one mole of diisocyanate, and in yet another embodiment no more than about 1 mole of monoalcohol per every one mole of diisocyanate, although the relative amounts can be outside of these ranges.

Examples of suitable catalysts include (but are not limited to) Lewis acid catalysts such as dibutyl tin dilaurate, bismuth tris-neodecanoate, cobalt benzoate, lithium acetate, stannous octoate, triethylamine, ferric chloride, aluminum trichloride, boron trichloride, boron trifluoride, titanium tetrachloride, tin tetrachloride, and the like. The catalyst, when present, is present in any desired or effective amount, in one embodiment at least about 0.2 mole percent, in another embodiment at least about 0.5 mole percent, and in yet another embodiment at least about 1 mole percent, and in one embodiment no more than about 10 mole percent, in another embodiment no more than about 7.5 mole percent, and in yet another embodiment no more than about 5 mole percent, based on the amount of diisocyanate, although the amount can be outside of these ranges.

Examples of suitable solvents for the first part of the reaction include (but are not limited to) toluene, hexane, heptane, methylene chloride, tetrahydrofuran, diethyl ether, ethyl acetate, methyl ethyl ketone, and the like, as well as mixtures thereof. When present, the solvent is present in any desired amount, in one embodiment at least about 10 milliliters per millimole of diisocyanate, in another embodiment at least about 20 milliliters per millimole of diisocyanate, in another embodiment at least about 30 milliliters per millimole of diisocyanate, and in one embodiment no more than about 100 milliliters per millimole of diisocyanate, in another embodiment no more than about 80 milliliters per millimole of diisocyanate, and in yet another embodiment no more than about 50 milliliters per millimole of diisocyanate, although the amount can be outside of these ranges.

The diisocyanate and the monoalcohol are heated to any desired or effective temperature, in one embodiment at least about 25° C., in another embodiment at least about 40° C., and in yet another embodiment at least about 50° C., and in one embodiment no more than about 125° C., in another embodiment no more than about 100° C., and in yet another embodiment no more than about 75° C., although the amounts can be outside of these ranges.

The diisocyanate and the monoalcohol are heated for any desired or effective period of time, in one embodiment at least about 5 minutes, in another embodiment at least about 10 minutes, and in yet another embodiment at least about 15 minutes, and in one embodiment no more than about 80 minutes, in another embodiment no more than about 40 minutes, and in yet another embodiment no more than about 30 minutes, although the time can be outside of these ranges.

Subsequent to the reaction between the diisocyanate and the monoalcohol, the first reaction product need not be recovered; the reaction mixture can be cooled to room temperature and the appropriately substituted 1,2-diaminocyclohexane can be added to the reaction mixture, along with additional solvent if desired, to complete the reaction.

The first reaction product and the 1,2-diaminocyclohexane are present in any desired or effective relative amounts, in one embodiment at least about 1.75 moles of first reaction product per every one mole of 1,2-diaminocyclohexane, in another embodiment at least about 1.9 moles of first reaction product per every one mole of 1,2-diaminocyclohexane, and in yet another embodiment at least about 2 moles of first reaction product per every one mole of 1,2-diaminocyclohexane, and in one embodiment no more than about 2.3 moles of first reaction product per every one mole of 1,2-diaminocyclohexane, in another embodiment no more than about 2.1 moles of first reaction product per every one mole of 1,2-diaminocyclohexane, and in yet another embodiment no more than about 2 moles of first reaction product per every one mole of 1,2-diaminocyclohexane, although the relative amounts can be outside of these ranges.

The first reaction product and the 1,2-diaminocyclohexane are allowed to react at any desired or effective temperature, in one embodiment at least about 10° C., in another embodiment at least about 20° C., and in yet another embodiment at least about 30° C., and in one embodiment no more than about 75° C., in another embodiment no more than about 50° C., and in yet another embodiment no more than about 40° C., although the temperature can be outside of these ranges.

The first reaction product and the 1,2-diaminocyclohexane are allowed to react for any desired or effective period of time, in one embodiment at least about 5 minutes, in another embodiment at least about 10 minutes, and in yet another embodiment at least about 20 minutes, and in one embodiment no more than about 3 hours, in another embodiment no more than about 1.5 hours, and in yet another embodiment no more than about 1 hour, although the time can be outside of these ranges.

Thereafter, the product can be precipitated by addition of a small amount of a non-solvent, such as hexane or methylene chloride, followed by good stirring. The product can then be recovered by filtration.

While not being limited to any particular theory, it is believed that the trans-1,2-cyclohexane bis(urea-urethane) compounds disclosed herein form reversible hydrogen bonds, resulting in the formation of oligomers and oligomer networks held together by non-covalent hydrogen bonds instead of covalent bonds. One example of such bond formation is illustrated as follows:

While not being limited to any particular theory, it is believed that in the inks containing these trans-1,2-cyclohexane bis (urea-urethane) compounds, at least some and perhaps all of these hydrogen bonds can be broken at the temperatures at which hot melt ink jet printing occurs (typically, although not necessarily, over 100° C.). When the ink is printed onto an intermediate transfer member or a final recording substrate, the ink cools as it is printed, which results in reformation of any hydrogen bonds broken by heating. The polymer-like materials thus formed behave like conventional covalently-bonded polymers to enhance image permanence. The image robustness can be increased by adding a trans-1,2-cyclohexane bis(urea-urethane) gelator compound to the ink. The gelator molecules can self-assemble into 3-dimensional fibrous networks by intermolecular hydrogen bonding and van der Waals interactions. The molten ink is expected to get trapped into these gel networks and form a semi-solid or a gel. In addition, the gelled inks exhibit visco-elastic rheological characteristics that are different from those of conventional hot melt or phase change inks in that they show an elastic behavior in a region where the ink is supposed to be in the liquid state. This behavior is evidenced by the crossover of G′ (storage modulus) and G″ (loss modulus), with G′ being higher than G″, indicating that the material is elastic. The elasticity of the material can also be expressed using tan-delta, which is defined as the ratio of G″ to G′, or G″/G′. A material which has a tan-delta of less than one is elastic, whereas a non-elastic material will not have a tan-delta of less than one above its melting point. The trons-1,2-cyclohexane bis(urea-urethane) gelator compounds, when present in phase change inks, can enable an intermediate gel phase wherein the gel phase transition entails a tan-delta of in one embodiment less than about 10, in another embodiment less than about 5, and in yet another embodiment less than about 1, although the tan-delta can be outside of these ranges. This elasticity can further enhance the robustness of images generated with the inks containing the trans-1,2-cyclohexane bis(urea-urethane) compounds. The trans-1,2-cyclohexane bis(urea-urethane) gelator compounds can also enable desirably narrow gel phase transitions in the inks, in one embodiment gel phase transitions 0.1 to 40° C. wide, in another embodiment gel phase transitions 0.1 to 20° C. wide, and in yet another embodiment gel phase transitions 0.1 to 15° C. wide, although the gel phase transitions can be outside of these ranges.

Phase change inks as disclosed herein in one specific embodiment exhibit a gel phase or state from about 1° C. to about 40° C. above the ink melting point, in another specific embodiment exhibit a gel phase or state from about 1° C. to about 20° C. above the ink melting point, and in yet another specific embodiment exhibit a gel phase or state from about 2° C. to about 15° C. above the ink melting point, although the gel phase or state can be exhibited outside of these ranges.

The formation of hydrogen-bonded oligomers or polymers from specific ink carrier materials can be determined by any desired method. For example, a dramatic onset of resinous and viscoelastic characteristics on cooling is indicative of the formation of hydrogen-bonded oligomers or polymers from the ink carrier material or combination of materials. The formation of hydrogen bonds and hydrogen-bonded oligomers or polymers can also be detected by IR spectroscopy. NMR spectroscopy may also help to detect the presence of hydrogen-bonded oligomers or polymers. In situations wherein the ink carrier material is crystalline, X-ray crystallography can be used to define the oligomeric or polymeric structure.

Further information on gels is disclosed in, for example, Gels Handbook, Vol. 1-4, Editors-in-Chief, Y. Osada and K. Kajiwara (translated by H. Ishida), 2001, Academic Press, the disclosure of which is totally incorporated herein by reference.

Specific embodiments will now be described in detail. These examples are intended to be illustrative, and the claims are not limited to the materials, conditions, or process parameters set forth in these embodiments. All parts and percentages are by weight unless otherwise indicated.

EXAMPLE I

To a solution containing 1,6-diisocyanatohexane (5.04 grams, 30 mmol; obtained from Sigma-Aldrich Fine Chemicals, Milwaukee, Wis.) and anhydrous tetrahydrofuran (100 milliliters) stirring at room temperature was added 1,4-butanediol vinyl ether (3.48 grams, 30 mmol; obtained from Sigma-Aldrich Fine Chemicals) and dibutyltin dilaurate (0.19 grams, 0.3 mmol; obtained from Sigma-Aldrich Fine Chemicals) as the catalyst. The mixture was stirred and heated to an internal temperature of about 65° C. for 25 minutes. The progress of the reaction was monitored by ¹H-NMR spectroscopy for consumption of the 1,4-butanediol vinyl ether reactant, indicated by the disappearance of the —CH₂OH multiplet, which appears at 3.5 ppm as a shoulder peak on the downfield end of the intermediate isocyanate product whose signal is located at 3.35-3.40 ppm. The mixture was cooled to about 15° C. internal temperature after which to this mixture was added dropwise a solution of trans-1,2-diaminocyclohexane (1.71 grams, 15 mmol; obtained as a racemic mixture of (1R,2R and (1S,2S) stereoisomers from Sigma-Aldrich Fine Chemicals) dissolved in anhydrous tetrahydrofuran (10 milliliters). The mixture was stirred for about 60 minutes while warming up to room temperature, and thickened to form a gelatinous slurry. FTIR spectroscospic analysis of a reaction sample showed little unreacted isocyanate (peak at 2180 cm⁻¹, sample prepared as a KBr pellet). Any residual isocyanate was quenched by addition of methanol (5 milliliters). The reaction mixture was then filtered by vacuum filtration to give a semi-solid product, which was subsequently stirred in hexane to ensure full precipitation. The solid product was filtered and dried in air to give 8.17 grams of a white powder (79 percent yield). The product was believed to be of the formulae

¹H-NMR spectroscopic analysis of the solid was performed in DMSO-d₆ (300 mHz) at high temperature (60° C.) and indicated the above structure with the following assigned peaks: 1.05-1.90 ppm (several multiplets, 16H integration, 4 methylene protons from 1,4-butanediol vinyl ether portion, 8 methylene protons from the 1,6-diisocyanatohexane portion, and 4 methylene protons from the cyclohexane ring portion); 2.95 ppm (multiplet, 4H integration, —NH(C═O)NHCH₂(CH₂)₄CH₂NH(C═O)O—); 3.2 ppm (broad singlet, 1H integration, tertiary methane proton adjacent to urea group on cyclohexane ring); 3.70 ppm (multiplet, 2H integration, NH(C═O)O(CH₂)₄—O—C(H_(c))═C(H_(a))(H_(b))); 3.96 ppm (doublet, 1H integration, —O—C(H_(c))═C(H_(a))(H_(b))); 3.98 ppm (multiplet, 2H integration, NH(C═O)OCH₂CH₂CH₂CH₂—O—C(H_(c))═C(H_(a))(H_(b))); 4.20 ppm (doublet, 1H integration, —O—C(H_(c))═C(H_(a))(H_(b))); 5.60 ppm and 5.72 ppm (broad singlets, each 1H integration, urea NH protons); 6.48 ppm (doublet of doublets, 1H integration, —O—C(H_(c))═C(H_(a))(H_(b))); 6.82 ppm (broad singlet, 1H integration, urethane NH proton). Elemental analysis calculated for C: 59.80%, H: 9.15%, N: 12.31%; found for C: 59.36%, H: 9.53%, N: 12.58%.

EXAMPLE II

Into a solution containing 1,12-diisocyanatododecane (5.04 grams, 20 mmol; obtained from Sigma-Aldrich Fine Chemicals) and a 1:1 mixture of hexane and tetrahydrofuran (75 milliliters) stirring at room temperature was added a solution containing triethylene glycol monomethacrylate (4.36 grams, 20 mmol; obtained as CD570 from Sartomer Company Inc., Exton, Pa.) dissolved in a 1:1 mixture of hexane and tetrahydrofuran (25 milliliters), and dibutyltin dilaurate (0.063 grams, 0.1 mmol; obtained from Sigma-Aldrich Fine Chemicals) as the catalyst. The mixture was stirred and heated to an internal temperature of 40° C. The progress of the reaction was monitored by ¹H-NMR spectroscopy for consumption of the triethylene glycol monomethacrylate reactant. The mixture was cooled to about 15° C. temperature, after which to this mixture was added dropwise a solution of trans-1,2-diaminocyclohexane (1.14 grams, 10 mmol; obtained as a racemic mixture of (1R,2R) and (1S,2S) stereoisomers from Sigma-Aldrich Fine Chemicals) dissolved in a 1:1 mixture of hexane and tetrahydrofuran (20 milliliters). The reaction mixture was stirred for 1 hour while warming up to room temperature. FTIR spectroscospic analysis of a reaction sample showed little unreacted isocyanate (peak at 2180 cm⁻¹, sample prepared as a KBr pellet). Any residual isocyanate reagent was quenched by addition of methanol (5 milliliters). The reaction mixture was then filtered by vacuum filtration to give 10.11 grams of a solid product as a white powder (96 percent yield). The product was believed to be of the formulae

¹H-NMR spectroscopic analysis of the solid was performed in DMSO-d₆ (300 MHz) at room temperature (25° C.) and indicated the above structure with the following assigned peaks: 1.10-1.80 ppm (multiplet, 24H integration, 20 protons from —NH—CH₂(CH₂)₁₀CH₂—NH— portion and 4 methylene protons from the cyclohexane ring portion); 1.90 ppm (singlet, 3H integration, —(C═O)C(CH₃)═CH₂); 2.95 ppm (narrow multiplet, 4H integration, —NH—CH₂(CH₂)₁₀CH₂—NH—); 3.35 ppm (multiplet, 1H, cyclohexane ring methine proton); 3.55 ppm (narrow multiplet, 8H integration, —(CH₂—O) protons); 4.07 ppm and 4.27 ppm (broad singlets, each 2H integration, NH(C═O)OCH₂CH₂)— and —OCH₂CH₂O(C═O)—C(CH₃)═CH₂); 5.70 ppm and 5.88 ppm (broad singlet, each 1H integration, urea NH protons); 5.70 ppm and 6.18 ppm (sharp singlet, each 1H integration, terminal vinyl protons —(C═O)C(CH₃)═CH₂); 7.15 ppm (broad singlet, 1H integration, urethane NH proton). Elemental analysis calculated for: C: 57.80%, H: 8.80%, N: 8.99%. Found for: C: 61.39%, H: 9.28%, N: 7.96%.

EXAMPLE III

Into a solution containing 1,6-diisocyanatohexane (4.03 grams, 24 mmol; obtained from Sigma-Aldrich Fine Chemicals) and a 1:1 mixture of hexane and tetrahydrofuran (100 milliliters) stirring at room temperature was added a solution containing triethylene glycol monomethacrylate (5.24 grams, 24 mmol; obtained as CD570 from Sartomer Company Inc., Exton, Pa.) dissolved in a 1:1 mixture of hexone and tetrahydrofuran (10 milliliters) and dibutyltin dilaurate (0.075 grams, 0.12 mmol (obtained from Sigma-Aldrich Fine Chemicals) as the catalyst. The mixture was stirred and heated to an internal temperature of 40° C. The progress of the reaction was monitored by ¹H-NMR spectroscopy for consumption of the triethylene glycol monomethacrylate reactant. The mixture was cooled to about 15° C. temperature, after which to this mixture was added dropwise a solution of trans-1,2-diaminocyclohexane (1.37 grams, 12 mmol; obtained as a racemic mixture of (1R,2R) and (1S,2S) stereoisomers from Sigma-Aldrich Fine Chemicals) dissolved in a 1:1 mixture of hexane and tetrahydrofuran (10 milliliters). The reaction mixture was stirred for 1 hour while warming up to room temperature. FTIR spectroscospic analysis of a reaction sample showed little unreacted isocyanate (peak at 2180 cm⁻¹, sample prepared as a KBr pellet). Any residual isocyanate reagent was quenched by addition of methanol (5 milliliters). The reaction mixture was then filtered by vacuum filtration to give 6.13 grams of a solid product as a white powder (58 percent yield). ¹H-NMR spectroscopic analysis of the solid was performed in DMSO-d₆ (300 MHz) at room temperature (25° C.) and exhibited spectral assignments that matched those found for the compound in Example II. The product was believed to be of the formulae

INK EXAMPLE 1

Mixtures comprising radiation curable materials and at least one organogelator compound were created to serve as ink vehicles for phase change radiation curable inks. The ink vehicle compositions contained UV-reactive diluents along with one or more organogelator compounds. The curable ink vehicles were prepared by weighing out the materials listed in the table below (amounts in parts by weight) and mixing them together with stirring at 80° C. for about 1 hour in amber-coated containers followed by cooling to room temperature. SR9003 is a reactive diluent known as propoxylated neopentylglycol diacrylate commercially available from Sartomer Company Inc. (Exton, Pa.). EB812 is Ebecryl 812 polyester acrylate oligomer commercially available from UCB Chemical Corp. (Smyrna, Ga.). SR494 and CN2300 are both multifunctional acrylate oligomers commercially available from Sartomer Company Inc. Upon cooling and equilibrating back to room temperature, the ink vehicle compositions had thickened to turbid gels exhibiting weak to moderate gel strength. Component Ink Vehicle 1 Ink Vehicle 2 Ink Vehicle 3 SR9003 reactive 6.58 6.228 6.912 diluent (Sartomer) EB812 (UCB) 1.41 1.650 1.469 SR494 (Sartomer) 0 1.670 1.434 CN2300 1.41 0 0 (Sartomer) Example II 0.60 0.301 0 organogelator Example III 0 0 0.304 organogelator

INK EXAMPLE 2

A radiation curable phase change ink is prepared by combining 152.1 grams of propoxylated neopentyl glycol diacrylate (known as SR9003 obtained from Sartomer Company Inc., Exton, Pa.), 39 grams of amine-modified polyether acrylate (PO 94F, available from BASF, Charlotte, N.C.), 6.0 grams of 2-benzyl-2-dimethylamino-1-(4-morpholinophenyl)butanone-1 (IRGACURE 369, available from Ciba, Tarrytown, N.Y.), 4.0 grams of isopropylthioxanthone (DAROCUR ITX, available from Ciba), and 4.0 grams of diphenyl-(2,4,6-trimethylbenzoyl)phosphine oxide (IRGACURE 819, available from Ciba) in a beaker and stirring until complete dissolution of the initiators is achieved. The gelator of Example III is then added in the amount of 3.2 grams and the mixture heated to 80° C. with stirring to dissolve the gelator. Propoxylated neopentyl glycol diacrylate (50 grams) is combined with 10 grams of Microlith Blue 4G-K pigment (available from Ciba Specialty Chemicals, Tarrytown, N.Y.) and stirred for 10 minutes. The pigment suspension is then subjected to 40 seconds of ultrasonic dispersion using a Fisher Scientific Sonic Dismembrator 500 equipped with a Branson 1020 ultrasonic probe employing a duty cycle of 10 seconds on, 20 seconds off and an intensity setting of 85 percent. The pigment dispersion is then heated gently to 80° C. with stirring and the previously prepared organogelator/photoinitiator/monomer/oligomer mixture also at 80° C. is slowly added to the dispersion.

Other embodiments and modifications of the present invention may occur to those of ordinary skill in the art subsequent to a review of the information presented herein; these embodiments and modifications, as well as equivalents thereof, are also included within the scope of this invention.

The recited order of processing elements or sequences, or the use of numbers, letters, or other designations therefor, is not intended to limit a claimed process to any order except as specified in the claim itself. 

1. Curable trans-1,2-cyclohexane bis(urea-urethane) compounds of the formulae

wherein R₁ and R′₁ each, independently of the other, is an alkylene group, an arylene group, an arylalkylene group, or an alkylarylene group, R₂ and R′₂ each, independently of the other, is an alkyl group, an aryl group, an arylalkyl group, or an alkylaryl group, R₃ and R′₃ each, independently of the other, is a hydrogen atom or an alkyl group, R₄ and R′₄ each, independently of the other, is a hydrogen atom, a fluorine atom, an alkyl group, or a phenyl group, n is an integer of 0, 1, 2, 3, or 4, and R₅ is an alkyl group, an aryl group, an arylalkyl group, an alkylaryl group, or a substituent other than an alkyl, aryl, arylalkyl, or alkylaryl group, provided that at least one of R₁, R′₁, R₂, R′₂, R₃, R′₃, R₄, R′₄, or one or more of R₅ is an alkyl, alkylene, arylalkyl, arylalkylene, alkylaryl, or alkylarylene group containing an ethylenic unsaturation rendering the compound curable upon exposure to heat and/or actinic radiation.
 2. Compounds according to claim 1 wherein at least one of R₁ and R′₁ is an alkylene group.
 3. Compounds according to claim 2 wherein at least one of R₁ and R′₁ is a linear alkylene group.
 4. Compounds according to claim 2 wherein at least one of R₁ and R′₁ is a branched alkylene group.
 5. Compounds according to claim 2 wherein at least one of R₁ and R′₁ is a cyclic alkylene group.
 6. Compounds according to claim 2 wherein at least one of R₁ and R′₁ is a substituted alkylene group.
 7. Compounds according to claim 2 wherein at least one of R₁ and R′₁ is an unsubstituted alkylene group.
 8. Compounds according to claim 2 wherein at least one of R₁ and R′₁ is an alkylene group having hetero atoms therein.
 9. Compounds according to claim 2 wherein at least one of R₁ and R′₁ is an alkylene group having no hetero atoms therein.
 10. Compounds according to claim 2 wherein at least one of R₁ and R′₁ is an alkylene group having at least 2 carbon atoms.
 11. Compounds according to claim 2 wherein at least one of R₁ and R′₁ is an alkylene group having at least about 6 carbon atoms.
 12. Compounds according to claim 2 wherein at least one of R₁ and R′₁ is an alkylene group having no more than about 60 carbon atoms.
 13. Compounds according to claim 2 wherein at least one of R₁ and R′₁ is an alkylene group having an ethylenic unsaturation therein.
 14. Compounds according to claim 1 wherein at least one of R₁ and R′₁ is an arylene, arylalkylene, or alkylarylene group.
 15. Compounds according to claim 14 wherein at least one of R₁ and R′₁ is a substituted arylene, arylalkylene, or alkylarylene group.
 16. Compounds according to claim 14 wherein at least one of R₁ and R′₁ is an unsubstituted arylene, arylalkylene, or alkylarylene group.
 17. Compounds according to claim 14 wherein at least one of R₁ and R′₁ is an arylene, arylalkylene, or alkylarylene group having hetero atoms therein.
 18. Compounds according to claim 14 wherein at least one of R₁ and R′₁ is an arylene, arylalkylene, or alkylarylene group having no hetero atoms therein.
 19. Compounds according to claim 14 wherein at least one of R₁ and R′₁ is an arylalkylene or alkylarylene group having an ethylenic unsaturation therein.
 20. Compounds according to claim 1 wherein R₁ and R′₁ are the same as each other.
 21. Compounds according to claim 1 wherein R₁ and R′₁ are different from each other.
 22. Compounds according to claim 1 wherein at least one of R₂ and R′₂ is an alkyl group.
 23. Compounds according to claim 22 wherein at least one of R₂ and R′₂ is a linear alkyl group.
 24. Compounds according to claim 22 wherein at least one of R₂ and R′₂ is a branched alkyl group.
 25. Compounds according to claim 22 wherein at least one of R₂ and R′₂ is a cyclic alkyl group.
 26. Compounds according to claim 22 wherein at least one of R₂ and R′₂ is a substituted alkyl group.
 27. Compounds according to claim 22 wherein at least one of R₂ and R′₂ is an unsubstituted alkyl group.
 28. Compounds according to claim 22 wherein at least one of R₂ and R′₂ is an alkyl group having hetero atoms therein.
 29. Compounds according to claim 22 wherein at least one of R₂ and R′₂ is an alkyl group having no hetero atoms therein.
 30. Compounds according to claim 22 wherein at least one of R₂ and R′₂ is an alkyl group having at least about 4 carbon atoms.
 31. Compounds according to claim 22 wherein at least one of R₂ and R′₂ is an alkyl group having at least about 10 carbon atoms.
 32. Compounds according to claim 22 wherein at least one of R₂ and R′₂ is an alkyl group having no more than about 60 carbon atoms.
 33. Compounds according to claim 22 wherein at least one of R₂ and R′₂ is an alkyl group having an ethylenic unsaturation therein.
 34. Compounds according to claim 1 wherein at least one of R₂ and R′₂ is an aryl, arylalkyl, or alkylaryl group.
 35. Compounds according to claim 34 wherein at least one of R₂ and R′₂ is a substituted aryl, arylalkyl, or alkylaryl group.
 36. Compounds according to claim 34 wherein at least one of R₂ and R′₂ is an unsubstituted aryl, arylalkyl, or alkylaryl group.
 37. Compounds according to claim 34 wherein at least one of R₂ and R′₂ is an aryl, arylalkyl, or alkylaryl group having hetero atoms therein.
 38. Compounds according to claim 34 wherein at least one of R₂ and R′₂ is an aryl, arylalkyl or alkylaryl group having no hetero atoms therein.
 39. Compounds according to claim 34 wherein at least one of R₂ and R′₂ is an arylalkyl or alkylaryl group having an ethylenic unsaturation therein.
 40. Compounds according to claim 1 wherein R₂ and R′₂ are the same as each other.
 41. Compounds according to claim 1 wherein R₂ and R′₂ are different from each other.
 42. Compounds according to claim 1 wherein R₁ and R′₁ are the same as each other and wherein R₂ and R′₂ are the same as each other.
 43. Compounds according to claim 1 wherein R₃ and R′₃ are each hydrogen atoms.
 44. Compounds according to claim 1 wherein at least one of R₃ and R′₃ is an alkyl group with from 1 to about 3 carbon atoms.
 45. Compounds according to claim 1 wherein R₃ and R′₃ are each hydrogen atoms, wherein R₁ and R′₁ are the same as each other, and wherein R₂ and R′₂ are the same as each other.
 46. Compounds according to claim 1 wherein R₄ and R′₄ are each hydrogen atoms.
 47. Compounds according to claim 1 wherein R₄ and R′₄ are each fluorine atoms.
 48. Compounds according to claim 1 wherein at least one of R₄ and R′₄ is an alkyl group.
 49. Compounds according to claim 1 wherein R₁ and R′₁ are the same as each other, R₂ and R′₂ are the same as each other, R₃ and R′₃ are each hydrogen atoms, R₄ and R′₄ are the same as each other, and R₄ and R′₄ are hydrogen atoms or fluorine atoms.
 50. Compounds according to claim 1 wherein R₁ and R′₁ are the same as each other, R₂ and R′₂ are the same as each other, R₃ and R′₃ are each hydrogen atoms, R₄ and R′₄ are the same as each other, R₄ and R′₄ are hydrogen atoms or fluorine atoms, and n is
 0. 51. Compounds according to claim 1 of the formulae


52. Compounds according to claim 1 of the formulae


53. Compounds according to claim 1 of the formulae 